Abanza, an Orlando, FL-based company which specializes in advanced soft tissue repair solutions, raised $5M in Pre-Series A funding.
The round was led by a family office specializing in medical device investments, along with private investors.
Led by CEO Juan Abascal, Ababza specializes in orthopedics and arthroscopic soft tissue repair. Committed to offering solutions and continuous improvement, it aims to enhance patient quality of life through the design and development of medical devices.
The company, which is set to improve medical device development with a focus on sports medicine and soft tissue repair/fixation, intends to use the funds to accelerate the U.S. launch of its soft tissue fixation product line, including the WasherCap™ and WasherCap™ Mini.
The WasherCap™ Fixation System has received FDA clearance for fixation of soft tissue grafts, including tendons and ligaments, during surgical procedures such as in Anterior Cruciate Ligament (ACL) reconstruction of the knee and has been used by a select group of surgeons in a preliminary launch. The company is also preparing to introduce the WasherCap™ Mini, which will cater to a wider range of applications including knee, hand, wrist, and elbow repairs.
Abanza is expanding its field sales team to work with leading orthopedic specialists across key U.S. markets. This expansion will evolve over time, with increased staffing, production capacity, and educational initiatives for physicians.
FinSMEs
05/09/2024